OR WAIT null SECS
Director, North and South America, Clinical TrialSystem and Auditing QA, RDQ, Bristol Myers Squibb
August 11, 2022
Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.